On May 12, 2025, President Trump signed an Executive Order titled: “Delivering Most-Favored-Nation Prescription Drug Pricing ...
With Regeneron poised to announce a drug pricing deal with the White House Thursday, all 17 companies targeted in a round of ...
Most Favored Nation (MFN) drug pricing is just price controls by another name. Instead of openly capping what a drug can cost ...
This White House deal will see Regeneron offer all its new medicines at “MFN prices”, while providing Otarmeni for free to eligible patients.
The renewed debate over Most Favored Nation (MFN) drug pricing in the United States reflects a legitimate frustration: ...
Hosted on MSN
Pharma R&D set to endure despite rising MFN costs
Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...
MFN policies are likely to impact more than pricing, and drug companies may alter drug launch plans in the future. With the launch of TrumpRx earlier this year, Americans got their first taste of how ...
Earlier this year, when the administration proposed deep cuts to the National Institutes of Health, lawmakers from both parties swiftly and rightly pushed back. Slashing medical research funding, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results